Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP6 | P55212 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | HCAR3 | P49019 | 12/20 | 0.54 |
| ▸ | APEX1 | P27695 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29886656 | 1.00 | CASP6 (0.64) | CASP6TSHRLMNAHCAR3APEX1 | |
| SCHEMBL615414 | 0.87 | CASP6 (0.64) | CASP6TSHRLMNAHCAR3APEX1 | |
| SCHEMBL5262777 | 0.85 | KMT2A (0.55) | CASP6TSHRLMNAHCAR3POLB | |
| SCHEMBL29886670 | 0.85 | ALDH1A1 (0.47) | CASP6TSHRLMNAPOLB | |
| SCHEMBL1727109 | 0.85 | PARP1 (0.59) | TSHRLMNAPOLB | |
| SCHEMBL3094851 | 0.85 | ALDH1A1 (0.47) | CASP6TSHRLMNAPOLB | |
| SCHEMBL3855174 | 0.83 | CASP6 (0.64) | CASP6TSHRLMNAHCAR3APEX1 | |
| SCHEMBL27967430 | 0.83 | HDAC6 (0.54) | CASP6TSHRLMNAPOLB | |
| SCHEMBL10219768 | 0.82 | CASP6 (0.49) | CASP6TSHRLMNAHCAR3APEX1 | |
| SCHEMBL13529954 | 0.81 | NOTUM (0.60) | TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119220056-B | Composite material based on fluorine-containing resin and preparation method thereof | 江西朝晖氟塑制品有限公司 | 2025-03-11 | — | — | CN | claimed |
| CN-119220056-A | Composite material based on fluorine-containing resin and preparation method thereof | 江西朝晖氟塑制品有限公司 | 2024-12-31 | — | — | CN | claimed |
| CN-108558672-B | Preparation method of 2-nitro-4-trifluoromethylbenzoic acid and isomer thereof | 利尔化学股份有限公司 | 2021-04-30 | — | — | CN | claimed |
| CN-108558672-A | The preparation method of 2- nitro -4- trifluoromethylbenzoic acids and its isomers | 利尔化学股份有限公司 | 2018-09-21 | — | — | CN | claimed |
| US-7732625-B2 | Colorant compounds | XEROX CORPORATION (US) | 2010-06-08 | — | — | US | claimed |
| US-7311767-B2 | Forming a salt of a liquid phase change ink carrier of stearyl stearamide, an amine substituted Xanthene, acridine, anthracene or thioxanthene chromogen, and a metal salt capable of forming a compound with two chromogens | XEROX CORPORATION (US) | 2007-12-25 | — | — | US | claimed |
| US-7033424-B2 | Phase change inks | XEROX CORPORATION (US) | 2006-04-25 | — | — | US | claimed |
| US-20060021546-A1 | Processes for preparing phase change inks | XEROX CORPORATION | 2006-02-02 | — | — | US | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060016369-A1 | PHASE CHANGE INKS | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-4845279-A | Method of preparing 4-trifluoromethyl-2-nitrobenzoic acid and novel isomer | CENTRAL GLASS COMPANY, LIMITED (JP) | 1989-07-04 | — | — | US | claimed |
| JP-1221356-A | — | — | None | — | — | JP | disclosed |
| CN-119220056-B | Composite material based on fluorine-containing resin and preparation method thereof | 江西朝晖氟塑制品有限公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-119220056-A | Composite material based on fluorine-containing resin and preparation method thereof | 江西朝晖氟塑制品有限公司 | 2024-12-31 | — | — | CN | disclosed |
| WO-2022138791-A1 | EP2 ANTAGONIST | 小野薬品工業株式会社 | 2022-06-30 | — | — | WO | disclosed |
| JP-H01221356-A | 3-AMINO-4-TRIFLUOROMETHYLBENZOIC ACID AND ITS PRODUCTION | CENTRAL GLASS CO LTD | 1989-09-04 | — | — | JP | disclosed |
| US-4845279-A | Method of preparing 4-trifluoromethyl-2-nitrobenzoic acid and novel isomer | CENTRAL GLASS COMPANY, LIMITED (JP) | 1989-07-04 | — | — | US | disclosed |
| US-4845279-A | Method of preparing 4-trifluoromethyl-2-nitrobenzoic acid and novel isomer | CENTRAL GLASS COMPANY, LIMITED (JP) | 1989-07-04 | — | — | US | disclosed |
| EP-0301692-A2 | 4,7-Benzofurandione derivatives | MERCK FROSST CANADA INC. (CA) | 1989-02-01 | — | — | EP | disclosed |
| EP-0295851-A1 | 4,7-diacyloxybenzofuran derivatives | MERCK FROSST CANADA INC. (CA) | 1988-12-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | CASP6 2660/4885TSHR 2894/4885LMNA 1769/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.